Next report date
Report period
Q1 2024
EPS estimate
−0.22USD
Revenue estimate
2.33 MUSD
−41.97 MUSD
6.77 MUSD
14.12 M
Om LAVA Therapeutics N.V.
Sektor
Bransch
VD
Stephen Allen Hurly
Webbplats
Huvudkvarter
Utrecht
Employees (FY)
37
Grundat
2016
ISIN
NL0015000AG6
FIGI
BBG00L04L545
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
